Table 2.
Different criteria among lung vs. others.
| Level | Non-Lung Cancers | Lung Cancer | p | |
|---|---|---|---|---|
| n | 103 | 41 | ||
| Antiphospholipid antibodies (%) | No | 100 (97.1) | 41 (100.0) | 0.647 |
| Yes | 3 (2.9) | 0 (0.0) | ||
| Primary cancer organ (%) | Gynecological | 23 (22.3) | 0 (0.0) | <0.001 |
| Lung | 0 (0.0) | 41 (100.0) | ||
| Other GIT cancers | 19 (18.4) | 0 (0.0) | ||
| Others | 33 (32.0) | 0 (0.0) | ||
| Pancreas | 28 (27.2) | 0 (0.0) | ||
| Pathology (%) | Adenocarcinoma | 60 (58.3) | 33 (80.5) | 0.004 |
| Hematopoietic | 6 (5.8) | 0 (0.0) | ||
| Others | 34 (33.0) | 4 (9.8) | ||
| Sarcoma | 1 (1.0) | 0 (0.0) | ||
| SCC | 2 (1.9) | 4 (9.8) | ||
| Adenocarcinoma vs. other pathologies (%) | Other pathologies | 43 (41.7) | 8 (19.5) | 0.02 |
| Adenocarcinoma | 60 (58.3) | 33 (80.5) | ||
| Organ of metastasis (n = 97) (%) | Bone | 3 (4.8) | 2 (5.9) | 0.258 |
| Brain | 2 (3.2) | 1 (2.9) | ||
| Liver | 20 (31.7) | 3 (8.8) | ||
| Lung | 5 (7.9) | 2 (5.9) | ||
| Lymph nodes | 11 (17.5) | 11 (32.4) | ||
| Multiple | 15 (23.8) | 10 (29.4) | ||
| Others | 7 (11.1) | 5 (14.7) | ||
| Metastasis (n = 141) (%) | Non-metastatic | 38 (37.6) | 5 (12.8) | 0.008 |
| Metastatic | 63 (62.4) | 34 (87.2) | ||
| Marantic presentation before diagnosis of cancer (n = 125) (%) | Known cancer case | 34 (36.2) | 8 (25.8) | 0.401 |
| Marantic as a first presentation | 60 (63.8) | 23 (74.2) | ||
| Interval diagnosis (months) (mean (SD)) | 7.95 (29.56) | 1.54 (3.81) | 0.257 | |
| Age (median (IQR)) | 59.00 (49.00, 65.00) | 61.00 (55.00, 67.00) | 0.389 | |
| Sex (%) | F | 63 (61.2) | 18 (45.0) | 0.118 |
| M | 40 (38.8) | 22 (55.0) | ||
| COPD (n = 52) (%) | No | 39 (97.5) | 10 (83.3) | 0.254 |
| Yes | 1 (2.5) | 2 (16.7) | ||
| Smoke (n = 56) (%) | No | 37 (92.5) | 6 (37.5) | <0.001 |
| Yes | 3 (7.5) | 10 (62.5) | ||
| Diabetes (n = 52) (%) | No | 31 (77.5) | 12 (100.0) | 0.17 |
| Yes | 9 (22.5) | 0 (0.0) | ||
| Obesity (n = 53) (%) | No | 40 (97.6) | 12 (100.0) | 1 |
| Yes | 1 (2.4) | 0 (0.0) | ||
| Dyslipidemia (n = 54) (%) | No | 35 (85.4) | 11 (84.6) | 1 |
| Yes | 6 (14.6) | 2 (15.4) | ||
| Hypertension (n = 56) (%) | No | 27 (64.3) | 9 (64.3) | 1 |
| Yes | 15 (35.7) | 5 (35.7) | ||
| Embolization event at presentation (n = 132) (%) | No | 12 (12.4) | 3 (8.6) | 0.767 |
| Yes | 85 (87.6) | 32 (91.4) | ||
| Embolic event after diagnosis (n = 125) (%) | No | 55 (59.1) | 21 (65.6) | 0.661 |
| Yes | 38 (40.9) | 11 (34.4) | ||
| Incidental finding of NBTE (%) | No | 95 (92.2) | 37 (90.2) | 0.956 |
| Yes | 8 (7.8) | 4 (9.8) | ||
| Postmortem diagnosis of NBTE (%) | No | 74 (71.8) | 21 (51.2) | 0.031 |
| Yes | 29 (28.2) | 20 (48.8) | ||
| Position of vegetation (n = 132) (%) | Aortic | 29 (31.2) | 19 (48.7) | 0.008 |
| Left atrium | 1 (1.1) | 0 (0.0) | ||
| Mitral | 42 (45.2) | 20 (51.3) | ||
| Multiple | 21 (22.6) | 0 (0.0) | ||
| Valve insufficiency (n = 89) (%) | No | 23 (35.4) | 5 (20.8) | 0.292 |
| yes | 42 (64.6) | 19 (79.2) | ||
| Valve stenosis (n = 90) (%) | No | 57 (86.4) | 24 (100.0) | 0.131 |
| Yes | 9 (13.6) | 0 (0.0) | ||
| Underwent intervention (%) | No | 84 (81.6) | 39 (95.1) | 0.069 |
| Yes | 19 (18.4) | 2 (4.9) | ||
| Type of surgery (%) | Excision of vegetation | 4 (3.9) | 1 (2.4) | 0.096 |
| None | 84 (81.6) | 39 (95.1) | ||
| Replacement | 15 (14.6) | 1 (2.4) | ||
| Presenting symptoms (n = 139) (%) | Cardiological | 4 (4.2) | 2 (5.6) | 0.467 |
| Neurological | 68 (70.8) | 28 (77.8) | ||
| Others | 4 (4.2) | 3 (8.3) | ||
| Respiratory | 11 (11.5) | 2 (5.6) | ||
| Vascular | 9 (9.4) | 1 (2.8) | ||
| Death (144) (%) | No | 37 (36.3) | 8 (20.0) | 0.094 |
| Yes | 65 (63.7) | 32 (80.0) | ||
| Time to death (days) (median (IQR)) | 19.60 (1.05, 56.00) | 10.99 (3.50, 35.28) | 0.64 |